The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients.
about
Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a reviewDietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.Biomarkers in peripheral arterial disease patients and near- and longer-term mortalityRacial variation in lipoprotein-associated phospholipase A₂ in older adults.Novel markers of peripheral arterial disease.Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and AtherosclerosisPlasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.Association between Ala379Val polymorphism of lipoprotein-associated phospholipase A2 and migraine without aura in Iranian populationLipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults.White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial diseaseIdentification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein.Lipoprotein-associated phospholipase A2, and subsequent cardiovascular events and mortality among patients with coronary heart disease.
P2860
Q26991853-12E54DA9-8C03-4305-A0E5-777C54332DC4Q33666216-F0C09A0D-2508-403D-9DB9-D236B5ADC10EQ33805731-4B1A19FD-8D63-4C10-9996-4E1907AA187EQ33828811-8CC72C4C-96BF-47B8-A16B-3505BF685890Q33946023-B833A2C2-D8C7-4055-ADC2-259C77B1BC97Q33984026-9D8FEF5E-F868-434E-BA29-483AC1657418Q35764402-2F5AA531-C20C-4227-A185-22CC1DA280C4Q36632984-46A2753A-9326-4E77-B0DC-33FA4DB153A6Q36730558-1EE960AF-0D98-4D6B-B611-788B08F56F07Q37017862-4BDF3C4B-D1E0-4847-B8BA-F620C5B31B78Q37244962-75E62711-80E5-4636-871E-7C0510650B02Q37445745-AD4264B5-0A66-4474-8B63-C33C8711756EQ39143403-DAFB04FB-433D-46CD-853E-F289AEF87E94Q40789562-C24B6E29-7518-4216-9CA3-98C365734E8A
P2860
The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The association between lipopr ...... in vascular medicine patients.
@en
type
label
The association between lipopr ...... in vascular medicine patients.
@en
prefLabel
The association between lipopr ...... in vascular medicine patients.
@en
P2093
P2860
P1476
The association between lipopr ...... in vascular medicine patients.
@en
P2093
Jeanenne J Nelson
Julie O Denenberg
Loki Natarajan
P2860
P304
P356
10.1016/J.JVS.2007.04.038
P577
2007-07-30T00:00:00Z